Trial Profile
The Effects of Celecoxib on Bone Ingrowth in Porous Coated Titanium Ceramic Implants in Humans
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Osteoarthritis; Postoperative pain
- Focus Pharmacodynamics
- 30 Sep 2008 Planned end date changed from 1 May 2009 to 1 Sep 2008 as reported by ClinicalTrials.gov.
- 30 Sep 2008 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 31 Jan 2008 New trial record.